Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pardoprunox Safety Extension in Early Parkinson's Disease
NCT00335374Phase 3Completed
- Sponsor
- Solvay
- Start
- Aug 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of pardoprunox in Parkinson's disease (PD), sponsored by Solvay. Started Aug 2007; status: completed.
02
Drugs
pardoprunox
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00335374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335374.